Global Search | Novartis

Hide Filters

Sort by

Relevance

Newest first

Oldest first

Showing 2663 results

Media Release / Mar 22, 2024
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
Positive CHMP opinion based on robust Phase III data, including APPLY-PNH, demonstrating superior hemoglobin improvement in the absence of transfusions with Fabhalta compared to anti-C5 therapy1-5 If…
Novartis annual results
Non-profit partnering for positive, sustainable social change
MS tools
Donations
Corporate governance
Media Library / Mar 01, 2024
Novartis radioligand therapy (RLT) manufacturing facility
Media Library / Mar 01, 2024
Radioligand therapy (RLT) production line
Media Library / Mar 01, 2024
Refrigeration room at a Novartis radioligand therapy (RLT) manufacturing facility
Media Library / Mar 01, 2024
Specialized equipment for the manufacture of radioligand therapy (RLT)

‹ Previous page
1
…
42
43
44
45
46
47
48
…
267
› Next page